Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1432-1439

Bentham Science Publishers

Access to resources Recommend Favorite

A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An Update

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 383-390

Bentham Science Publishers

Access to resources Recommend Favorite

Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 447-451

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease and Type 2 Diabetes: What Is the Connection?

By  

The Consultant Pharmacist, Vol. 30, Iss. 2, 2015-02 ,pp. : 112-115

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Major Depressive Disorder and Type II Diabetes Mellitus: Mechanisms Underlying Risk for Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1740-1749

Bentham Science Publishers

Access to resources Recommend Favorite